Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-10-021795)

Filing Details

Accession Number:: 0001144204-10-021795
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-22 13:00:00
Reporting Period:: 2010-04-21

Filing Date:: 2010-04-22
Accepted Time:: 2010-04-22 19:49:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1174228	Nurx Pharmaceuticals Inc.	NUXP.OB	Medicinal Chemicals & Botanical Products (2833)	870681500

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1420266	Harin Padma-Nathan	9100 Wilshire Blvd. Bevely Hills CA 90212	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-21	2,777,778	$0.00	2,777,778	No	4	P	Indirect	UBS Financial Custodian FBO Harin Padma-Nathan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	UBS Financial Custodian FBO Harin Padma-Nathan

Footnotes

The reporting person acquired the shares of common stock pursuant to a certain Stock Purchase Agreement dated as of April 9, 2010 for an aggregate purchase price of $250,000.